Document Actions
Haematology Speakers 2010
Dr Drew Provan
Drew Provan is a general haematologist with a specific interest in immunohaematology. He is currently Senior Lecturer in Haematology at Bart’s & The London School of Medicine and Dentistry.
He studied molecular genetics at Leicester University before studying medicine. After junior medical posts in Scotland, Nottingham and Yorkshire, in 1993 he went to the Dana-Farber Cancer Institute in Boston, on an American travelling fellowship awarded by the Medical Research Council. He took up the post of consultant haematologist in Southampton in 1995, and moved to Barts & The London in 2000. He enjoys writing and editing and has been involved in the production of a number of books, including MRCP and MRCPath examination books, in addition to Molecular Haematology (Blackwell Science), Oxford Handbook of Clinical Haematology and Oxford Handbook of Clinical & Laboratory Investigation, and the ABC of Clinical Haematology (BMJ books).
Professor Tony Green
Tony Green is Head of the University of Cambridge Department of Haematology and Chairman of Addenbrooke's NHS Trust Department of Haematology. He trained in medicine at the University of Cambridge and University College Hospital London completing his haematology training at the Royal Free Hospital and the University Hospital of Wales, Cardiff. His scientific training in molecular biology and haematopoiesis was gained at the Imperial Cancer Research Fund, London and the Walter and Eliza Hall Institute, Melbourne, the latter as a Hamilton-Fairley Travelling Fellow. He moved to Cambridge in 1991 as a Welcome Trust Senior Fellow and was elected to the Chair of Haemato-Oncology there in 1999. His research interests focus on two aspects of haematopoietic stem cell biology: the molecular pathogenesis of myeloid malignancies and the transcriptional regulation of haematopoietic stem. Clinical research activities are mainly in the area of the myeloproliferative disorders.
Dr Robert Marcus
Robert Marcus qualified in medicine and pursued postgraduate studies in haematology at University College Hospital in London, subsequently becoming a research fellow at the MRC leukaemia unit at the Hammersmith Hospital, London. Dr Marcus completed his training in haematology at the Royal Free Hospital in London. He was appointed consultant haematologist at Addenbrooke’s Hospital in Cambridge in 1987 and participated in the first clinical studies in monoclonal antibody therapy for lymphoma with the CAMPATH series of antibodies. Dr Marcus later developed an interest in the development of novel treatments for lymphoma and has been chief investigator in a large number of phase 2 and 3 studies of chemotherapy and immunotherapy in lymphoma. He established stem cell transplantation in Cambridge and was, until recently, lead cancer clinician for Addenbrooke’s Hospital. Dr Marcus has published many papers and reviews on lymphoma and related topics in peer-reviewed journals and is the senior editor and contributor to the textbook, Lymphoma – pathology, diagnosis and treatment, published by Cambridge University Press in 2007. He is chairman of the NCRI low-grade lymphoma subgroup and has been consultant haematologist at King’s College Hospital, London, UK since February 2008.
Dr Trevor Baglin
Trevor Baglin qualified in medicine from the University of Manchester with distinction in internal medicine in 1981. He then trained in internal medicine at Manchester and Newcastle-Upon-Tyne and in haematology at Birmingham and Cambridge. In 1989 he was awarded a PhD by the University of Birmingham for his thesis on platelet activation. Since 1990 Dr Baglin has been a consultant haematologist at Addenbrooke’s Hospital in Cambridge. He is the President-Elect of the British Society for Haemostasis and Thrombosis.
His main clinical and research interests are in haemostasis and thrombosis and he has developed a multidisciplinary team for the prevention and treatment of bleeding and thrombotic disorders, promoting out of hospital care and self management. Dr Baglin’s main research interests are in the regulation of thrombin generation and the use of laboratory tests as a measure of thrombosis risk. He has published more than 200 original clinical and scientific articles in peer-reviewed journals and for the past 6 years has been chairman of the haemostasis and thrombosis task force for the British Society for Haematology. He is an elected member of the scientific and standardisation subcommittee for the International Society for Haemostasis and Thrombosis (ISTH) and chairman of the subcommittee for control of anticoagulation for the ISTH.
He has held several appointments as an adviser on healthcare standards, including chairman of the regional haematology professional development group, chairman of the UK National External Quality Assessment Scheme (Coagulation) Steering Committee, regional adviser to the Royal College of Pathologists. He was also director of medical education at Addenbrooke’s Hospital from 1997 to 2000 and lead clinician for clinical governance at Addenbrooke’s Hospital from 2001 to 2008.
Dr Jim Murray
Dr Murray trained at Edinburgh and Sheffield before moving to Birmingham. He is a general haematologist with an interest in morphology. He is secretary of the BCSH General Haematology task Force and Chair of the Panel of Examiners for Haematology.
